Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|14|12|1385-1391
ISSN： 1389-4501
Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1385-1391
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology
Current Medicinal Chemistry, Vol. 24, Iss. 11, 2017-05 ,pp. :
Access to resources
Recommend
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. :
Treatment of Inflammatory Bowel Disease in the Elderly: An Update
By Pardi D.S. Loftus Jr E.V. Camilleri M.
Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. :